Literature DB >> 19609895

Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy.

Jeffrey B Geske1, Paul Sorajja, Steve R Ommen, Rick A Nishimura.   

Abstract

BACKGROUND: The presence and magnitude of left ventricular outflow tract (LVOT) obstruction directs the management algorithm in symptomatic patients with hypertrophic cardiomyopathy (HCM). Although it is well known that the degree of LVOT obstruction is dynamic and dependent upon ventricular load and contractility, the magnitude and potential impact of the day-to-day variability seen in practice has not been well appreciated. HYPOTHESES: We hypothesized that LVOT gradient variability in HCM has an impact on clinical decision-making.
METHODS: A total of 100 HCM patients (mean age, 58 +/- 13 years; 47% male) underwent comprehensive 2-dimensional Doppler transthoracic echocardiography and cardiac catheterization with transseptal measurement of left-sided pressures. All studies were performed within 48 hours of one another.
RESULTS: The correlation of LVOT gradients from both methods performed at different times had a wide scatter with the 95% confidence limits of agreement being +/- 84 mm Hg. For classifying patients as having severe LVOT obstruction on the basis of either method (<30 vs > or = 30 mm Hg), discrepant results occurred in 21% of patients. To confirm the accuracy of Doppler measurements, 15 studies were performed with simultaneous measurement of LVOT gradient, which revealed a very strong correlation (r = 0.98, p < 0.0001) with 95% confidence limits of agreement +/- 12 mm Hg.
CONCLUSIONS: In patients with HCM, LVOT gradient measurements are routinely obtained to characterize the severity of obstruction. However, these data demonstrate the marked variability of the LVOT obstruction, which must be considered when determining appropriate therapy in symptomatic patients.

Entities:  

Mesh:

Year:  2009        PMID: 19609895      PMCID: PMC6653614          DOI: 10.1002/clc.20594

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  11 in total

Review 1.  The Muscle-Bound Heart.

Authors:  Marwan M Refaat; Akl C Fahed; Sylvana Hassanieh; Mostafa Hotait; Mariam Arabi; Hadi Skouri; Jonathan G Seidman; Christine E Seidman; Fadi F Bitar; Georges Nemer
Journal:  Card Electrophysiol Clin       Date:  2016-03

2.  Hypotension due to dynamic left ventricular outflow tract obstruction after percutaneous coronary intervention.

Authors:  Ali Dahhan; Almois Mohammad; Deepak Kapoor; Gyanendra K Sharma
Journal:  Tex Heart Inst J       Date:  2011

3.  Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction.

Authors:  Jens Vogel-Claussen; Miguel Santaularia Tomas; Amit Newatia; Danielle Boyce; Aurelio Pinheiro; Roselle Abraham; Theodore Abraham; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2012-05-01       Impact factor: 4.813

4.  Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.

Authors:  Pierpaolo Palumbo; Francesco Masedu; Camilla De Cataldo; Ester Cannizzaro; Federico Bruno; Silvia Pradella; Francesco Arrigoni; Marco Valenti; Alessandra Splendiani; Antonio Barile; Andrea Giovagnoni; Carlo Masciocchi; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2021-12-11       Impact factor: 3.469

Review 5.  Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.

Authors:  Daniel J Philipson; Eugene C DePasquale; Eric H Yang; Arnold S Baas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 6.  Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management.

Authors:  C Charles Jain; Darrell B Newman; Jeffrey B Geske
Journal:  Curr Cardiol Rep       Date:  2019-10-31       Impact factor: 2.931

7.  Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Monika Gawor; Agata Kubik; Ewa Kowalik; Barbara Miłosz-Wieczorek; Maciej Dąbrowski; Konrad Werys; Łukasz Mazurkiewicz; Katarzyna Kożuch; Magdalena Polańska-Skrzypczyk; Joanna Petryka-Mazurkiewicz; Anna Klisiewicz; Zofia T Bilińska; Jacek Grzybowski; Adam Witkowski; Magdalena Marczak
Journal:  J Cardiovasc Magn Reson       Date:  2017-12-21       Impact factor: 5.364

Review 8.  Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Authors:  Srijita Sen-Chowdhry; Daniel Jacoby; James C Moon; William J McKenna
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

9.  In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness.

Authors:  Katja Hueper; Antonia Zapf; Jan Skrok; Aurelio Pinheiro; Thomas A Goldstein; Jie Zheng; Stefan L Zimmerman; Ihab R Kamel; Roselle Abraham; Frank Wacker; David A Bluemke; Theodore Abraham; Jens Vogel-Claussen
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

10.  Provocation of left ventricular outflow tract obstruction using nitrate inhalation in hypertrophic cardiomyopathy: Relation to electromechanical delay.

Authors:  Hala Mahfouz Badran; Waleed Abdou Ibrahim; Naglaa Faheem; Rehab Yassin; Tamer Alashkar; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.